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The yeast two-hybrid system de-
tects in vivo protein-protein interac-
tions leading to the reconstitution of
transcription factor activity. The DNA
binding domain (DBD) and the activa-
tion domain (AD) of this transcription
factor are both expressed within the
same cell, but on different fusion pro-
teins (the “bait” and “prey” fusions, re-
spectively). Active transcription factor
is then only reconstituted when these
DBD- and AD-bearing fusions associ-
ate noncovalently in the yeast nucleus.
The transcription factor activity is
monitored through the reporter genes
integrated in the genomes of the yeasts
used for two-hybrid screening (1).
The strength of the two-hybrid ap-
proach is that it reveals protein-protein
interactions in the context of the living
cell. More confidence can be placed on
such interaction data if they are known
to involve protein fusions that are still
functional—in other words, that neither
the DBD or AD domain addition nor
the targeting of the protein fusion to the
nucleus has caused loss of functionality.
Existing two-hybrid vectors generally
position the DBD or AD domain at the
N-terminus of the protein of interest
(1,2). However, there are occasions
when it is preferable to fuse this domain
to the protein’s C terminus (e.g., when
this allows preservation of the biologi-
cal function or provides less self-activa-
tion in the two-hybrid system than the
corresponding N-terminal fusion). To
this end, vectors have been described
for placing the LexA DBD at the C-ter-
minus (3). Here we describe plasmids
that allow both N-terminal and C-termi-
nal fusions to be made with the same
vector. These, a slight modification of
the pOBD2 and pOAD vectors from the
latest development of the Fields two-
hybrid system (2), facilitate fusion of
the Gal4p DBD or Gal4p AD to either
the N  or C terminus of any protein of
interest. This in turn allows rapid iden-
tification of which fusion construct is
most suitable for two-hybrid screening.
We show an example where positioning
the Gal4p DBD at a protein C terminus
generates a functional protein fusion,
suitable for use in two-hybrid screen-
ing, but where the corresponding N-ter-
minal DBD addition causes both loss of
functionality and self-activation in the
two-hybrid system.
Vector pBDC (Figure 1) was con-
structed by introducing a unique NruI
restriction endonuclease site upstream
of the Gal4p DBD gene in the TRP1
vector pOBD2 (2). pBDC is slightly
more versatile than the parent pOBD2
in that it can be used to position this
DBD at either the N or C terminus of
any open reading frame (ORF). Gener-
ation of N-terminal DBD fusions is
through in vivo recombination in yeast
between NcoI plus PvuII-cut pBDC (or
pOBD2) and the ORF of interest as a
linear fragment [the latter generated by
two sequential PCR amplifications, us-
ing primers with the sequence exten-
sions described in an earlier report (2)].
Generation of C-terminal DBD fusions
is also through a recombination in yeast
between linearized pBDC and the ORF
as a PCR product, but in this case the
pBDC is linearized with NruI (Figure
1) and the ORF-encoding DNA is cre-
ated using PCR primers with different
sequence extensions. The first PCR
used to generate the latter DNA uses
primers that possess 3′ sequence ho-
mologies to the ORF of interest, but 5′
homologies to the vector [forward
primer gcttgaagcaagcctcg ATG ***
*** *** *** *** *** ***; reverse
primer: cagtagcttcatctttcg*** *** ***
*** *** *** *** (ATG *** ***, etc.,
corresponding to the codons of the
ORF and lowercase letters the se-
quences of the pBDC vector)]. The
product of this first PCR is then used as
the template in a second round of PCR
that uses primers completely homolo-
gous to regions flanking the NruI site of
pBDC (forward primer: caactccaagc-
ttgaagcaagcctcgatg; reverse primer:
cgatagaagacagtagcttcatctttcg).
In a similar way, vector pADC (Fig-
ure 1) can be used to position the Gal4
AD at either the N or C terminus of an
ORF. N-terminal AD fusions are gener-
ated by an in vivo recombination be-
tween NcoI plus PvuII-cut pADC [or
pOAD (2)] and the ORF as a linear
Figure 1. Vectors pBDC and pADC. These plasmids were derived from pOBD2 and pOAD, respec-
tively (2), by changing the pOBD2 sequence at -9 to -4 with respect to the Gal4-DBD initiator codon to
TCGCGA and the pOAD sequence at -13 to -8 relative to the Gal4p AD to AAGCTT. Each of these se-
quence changes introduced a unique NruI restriction site.
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PCR product [generated in two sequen-
tial amplifications, using primers with
sequence extensions described in an
earlier report (2)]. Generation of fu-
sions where the AD is positioned at the
ORF C terminus is through in vivo re-
combination between NruI-cut pADC
(Figure 1) and an ORF-encoding frag-
ment. The latter is again generated by
two sequential PCR amplifications, the
first using primers with 3′ sequence ho-
mologies to the ORF, but 5′ sequence
homologies to the vector (forward
primer: agcatacaatccaag ATG *** ***
*** *** *** *** *** *; reverse primer:
cgctttatccatctttgcaaaggc *** *** ***
*** *** *** *** *). The product of this
first reaction is then used as the tem-
plate in a second round of PCR, using
primers homologous to the regions
flanking the pADC NruI site (forward
primer: caagctataccaagcatacaatccaag-
atg; reverse primer: ggaattaattccgctt-
tatccatctttgcaaaggc).
Figure 2 shows a situation where
positioning the Gal4p DBD at a protein
N terminus generates a fusion that self-
activates in the two-hybrid system and
that has totally lost functionality, but
where the corresponding C-terminal fu-
sion does not self-activate and retains
biological activity. Heat shock protein
90 (Hsp90) is a chaperone essential for
the activity of several key signaling and
regulatory proteins in eukaryotic cells.
It binds these proteins when they are al-
ready substantially folded. Then, in re-
sponse to the appropriate activatory
signals, it induces the protein associa-
tions that are needed for these “client”
proteins to attain full activity (4,5).
Placing the Gal4p DBD at the Hsp90 N
terminus produces a fusion that is inca-
pable of providing Hsp90 function in
yeast (6), probably because this domain
addition interferes with intra- and inter-
molecular interactions at the Hsp90 N
terminus that are critical in the Hsp90
chaperone cycle (7). On the premise
that a protein fusion that is also a func-
tional chaperone would be more likely
to display the true interactions of
Hsp90 in the two-hybrid system, we in-
vestigated if it might not be preferable
to express Hsp90 with a C-terminal
DBD extension. The PJ694α Saccha-
romyces cerevisiae strain used for two-
hybrid screening (2) was transformed,
as described above, so that it expressed
either N- or C-terminal Gal4p DBD fu-
sions to the major isoform of yeast
Hsp90 (Hsc82). To determine if these
fusions can confer Hsp90 function, we
recovered the TRP1 plasmids that car-
ried these DBD-HSC82 and HSC82-
DBD fusion genes from the original
PJ694α transformants. We then retrans-
formed them into another yeast, a strain
that can be used to test for Hsp90 func-
tionality (PP30[pHSC82] (MATa trp1-
289, leu2-3,112, his3-200, ura3-52,
ade2-101oc, lys2-801am, hsc82::KAN-
MX4, hsp82::KANMX4 [pHSC82]) (8).
Yeast deleted for both Hsp90 genes is
normally inviable, but strain PP30
[pHSC82] is viable because it carries
the HSC82 gene for Hsc82 on a URA3
episomal plasmid (pHSC82). By intro-
ducing Hsp90 genes into PP30
[pHSC82] on LEU2, TRP1, or HIS3
vectors and then selecting for the loss
of the original pHSC82 URA3 vector
[using medium containing 5-fluo-
roorotic acid (FOA), a compound toxic
to URA3 gene-bearing cells], it is possi-
ble to determine if these introduced
genes can confer the essential Hsp90
function. Growth on FOA reveals the
introduced Hsp90 gene is functional,
whereas the absence of FOA growth
shows it is nonfunctional (8,9). Our
pBDC-derived plasmid encoding
Hsc82 with a C-terminal DBD exten-
sion (Hsc82-DBD) could confer such
Hsp90 function, whereas the plasmid
coding for Hsc82 with an N-terminal
DBD extension (DBD-Hsc82) could
not (Figure 2a).
Expression of the nonfunctional
DBD-Hsc82 fusion also resulted in ap-
preciable self-activation in the two-hy-
brid system. This was apparent from
the capacity of this fusion to confer
high expression of the Gal1p-regulated
HIS3 and LacZ genes in the PJ694α
two-hybrid strain (2) [evident from the
strong growth in the presence of high
levels of 3-aminotriazole (3-AT; an in-
hibitor of the His3p histidine biosyn-
thetic pathway enzyme); Figure 2, b
and c; and high LacZ expression (Fig-
ure 2d)]. This high level of self-activa-
tion precludes the use of this nonfunc-
tional DBD-Hsp82 fusion as “bait” in
two-hybrid screening. In contrast, the
functional Hsc82-DBD fusion (Figure
2a) did not self-activate (growth of
PJ694α containing this construct be-
ing inhibited at 0.5 mM 3-AT; Figure
2, b and c). However, it was expressed
at similar levels to the DBD-Hsc82 fu-
sion (Figure 2f). The latter Hsc82-
DBD fusion was recently used in a
study of Hsp90’s interactions with a
newly discovered Hsp90 system co-
chaperone, AhaI (10). PJ694α cells
containing this fusion have also been
mated to the array of AD-protein fu-
sions corresponding to at least
80%–90% of the proteins of yeast [ex-
pressed in a strain of the opposite mat-
ing type, PJ469a (2)]. In the latter
screen, no strong interactors with
Hsc82-DBD were detected, which is
consistent with the probable transience
of most chaperone interactions. There
were, however, a number of relatively
weak Hsp90-protein interactions.
Many of the latter were to known ac-
cessory proteins (co-chaperones) of
the Hsp90 chaperone system, consis-
tent with detection of biologically
meaningful protein-protein interac-
tions (manuscript in preparation).
There are probably other instances
where, when an N-terminal domain fu-
sion is found to self-activate in the
two-hybrid system, the use of the cor-
responding C-terminal fusion will
overcome this problem and permit a
two-hybrid screen.
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Figure 2. Characterization of the consequences of DBD-HSC82 and HSC82-DBD fusion gene ex-
pression in yeast. (a) FOA growth of yeast strain PP30[pHSC82] transformed with empty pBDC and
pBDC-derived plasmids bearing DBD-HSC82 and HSC82-DBD fusion genes. (b–d) Growth of PJ694α
cells bearing the same TRP1 vectors in the presence of the indicated levels of 3-AT. (e) LacZ expression
levels in the same PJ694α cells. (f) A Western blot probed with an anti-yeast Hsp90 rabbit polyclonal
antiserum (9) showing the similar levels of DBD-Hsp82 and Hsp82-DBD expression in these cells (the
signal from the native Hsp90s of these yeasts provides an internal control for equal gel loading).
